A 21-Day, Randomized, Controlled Study to Evaluate the Skin Irritation Potential of FMX-101 in Healthy Volunteers Using a Cumulative Irritant Patch Test Design
Latest Information Update: 20 May 2021
At a glance
- Drugs Minocycline (Primary)
- Indications Acne vulgaris; Impetigo; Rosacea
- Focus Adverse reactions
- Sponsors VYNE Therapeutics
Most Recent Events
- 22 Aug 2019 New trial record